Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)

General Information of Drug (ID: DR0552)
Drug Name
Droxidopa
Prodrug Info Droxidopa is the prodrug of Norepinephrine
Synonyms
DL-threo-3,4-Dihydroxyphenylserine; DL-threo-DOPS; DL-threo-Dihydroxyphenylserine; DL-threo-Droxidopa; Droxidopa (L-DOPS); L-DOPS; L-Threodops; L-threo-dihydroxyphenylserine; Northera; SM 5688; droxidopa; threo-Dopaserine; (2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid; 23651-95-8; 3916-18-5; BRN 2852792; CHEBI:31524; DL-threo-3-(3,4-Dihydroxyphenyl)serine; DOPS; EINECS 223-480-5; Serine, 3-(3,4-dihydroxyphenyl)-, DL-threo-; UNII-J7A92W69L7; beta,3-Dihydroxy-DL-tyrosine threo-; threo-beta,3-Dihydroxy-DL-tyrosine
Indication Neurogenic orthostatic hypotension [ICD11: 8D87] Approved [1]
Structure
3D MOL 2D MOL
Pharmaceutical Properties Molecular Weight 213.19 Topological Polar Surface Area 124
Heavy Atom Count 15 Rotatable Bond Count 3
Hydrogen Bond Donor Count 5 Hydrogen Bond Acceptor Count 6
Cross-matching ID
PubChem CID
92974
PubChem SID
7848340 ; 10225708 ; 12013905 ; 14748940 ; 15220262 ; 44423747 ; 50045941 ; 50370475 ; 57335461 ; 103851036 ; 104408862 ; 117541347 ; 118311826 ; 126654108 ; 134995608 ; 135050567 ; 137323634 ; 138163335 ; 152029318 ; 160692469 ; 160824963 ; 162009751 ; 162228197 ; 163092402 ; 163384817 ; 163773158 ; 163883713 ; 172855924 ; 175612534 ; 178103963 ; 179150202 ; 196106149 ; 198948648 ; 204433783 ; 210274860 ; 210280493 ; 223441551 ; 226502358 ; 241076804 ; 242660130 ; 249492214 ; 252348725 ; 252418289
ChEBI ID
CHEBI:31524
CAS Number
23651-95-8
TTD Drug ID
D0I3RO
Formula
C9H11NO5
Canonical SMILES
C1=CC(=C(C=C1C(C(C(=O)O)N)O)O)O
InChI
1S/C9H11NO5/c10-7(9(14)15)8(13)4-1-2-5(11)6(12)3-4/h1-3,7-8,11-13H,10H2,(H,14,15)/t7-,8+/m0/s1
InChIKey
QXWYKJLNLSIPIN-JGVFFNPUSA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
Norepinephrine DM000282
439260
Oxidation - Decarboxylation 1 [3]
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR014193 Droxidopa Norepinephrine Oxidation - Decarboxylation DDC [3]
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
DOPA decarboxylase (DDC) DME0125 Homo sapiens
DDC_HUMAN
4.1.1.28
[2]
References
1 Droxidopa was approved by FDA. The 2020 official website of the U.S. Food and Drug Administration.
2 L-Dihydroxyphenylserine (L-DOPS): a norepinephrine prodrug. Cardiovasc Drug Rev. 2006 Fall-Winter;24(3-4):189-203.
3 FDA LABEL:Droxidopa

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.